FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We have now added a new section called the "Assay History List" to the "At A Gla...